‍

genOway’s presentation at the 2nd T-Cell Engager for Autoimmune Disease Summit, Boston 2026

‍

Wednesday, October 28, 2026, 14:00-14:30

発表者：カデル・ティアム、最高戦略責任者（CSO）兼上級副社長（SVP）－ ディスカバリー、前臨床モデルおよびサービス担当

Title: "BRGSF-HIS: A Translational Model for B Cell-Targeting TCEs in Autoimmunity​"

• Robust human lymphoid and myeloid reconstitution without GvHD, enabling long-term immunotherapy studies.
• Clinically relevant B-cell depletion and T-cell pharmacodynamics with therapies targeting autoreactive B cells.
• Integrated efficacy and CRS-like safety assessment in a single translational platform.

‍

We look forwards meeting you there!